The statement relates to one of the three intended Procter and Gamble publications about change in bone turnover and fractures in patients taking Actonel (Eastell et al. 2003 JBMR 18:1051-6). The other two publications based on overlapping data have only been published in abstract form. The intended first author declined to sign journal declarations while being refused access to underlying raw data.
Medical journals face a crisis of credibility (1-15). Collated correspondence with the JBMR over 2 years provides some insight into the real concerns underlying their "Statement of Concern".
And from (11) a quotation that provides an excellent summary of the crisis facing medicine.
- 23 August 2006: Why Today's JAMA Editorial Doesn't Go Far Enough
- PLoS takes a stand
- NEJM and Vioxx
- Manipulating a Journal Article: NYT
- Audio interview with NEJM Editor Drazen -(the call from Hrachovec begins at 44:30)
- For Science's Gatekeepers, a Credibility Gap
- Just how much 'new research' can we trust?
- Incident raises questions of editors' and publishers' corporate connections
- Why you can't trust medical journals anymore
- Commercial influence and the content of medical journals
- Presentation by Gavin Yamey
- A Story Involving JAMA, Harvard Medical School, Baxter International, Cytyc
- More on lessons from Neuropsychopharmacology
- Won't Get Fooled Again, Again, Again
- About the paper in Am J Psychiatry 163:34A (2006)